Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study

被引:12
|
作者
Scholes, Shaun [1 ]
Bajekal, Madhavi [1 ]
Norman, Paul [2 ]
O'Flaherty, Martin [3 ]
Hawkins, Nathaniel [4 ]
Kivimaeki, Mika [5 ]
Capewell, Simon [3 ]
Raine, Rosalind [1 ]
机构
[1] UCL, Dept Appl Hlth Res, London, England
[2] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Liverpool, Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Liverpool L69 3BX, Merseyside, England
[4] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England
[5] UCL, Dept Epidemiol & Publ Hlth, London, England
来源
PLOS ONE | 2013年 / 8卷 / 07期
基金
英国经济与社会研究理事会; 美国国家卫生研究院; 英国医学研究理事会;
关键词
CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; TRENDS; ADULTS; ASSOCIATIONS; METAANALYSIS; PREVALENCE;
D O I
10.1371/journal.pone.0069935
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aims: To estimate the number of coronary heart disease (CHD) deaths potentially preventable in England in 2020 comparing four risk factor change scenarios. Methods and Results: Using 2007 as baseline, the IMPACT(SEC) model was extended to estimate the potential number of CHD deaths preventable in England in 2020 by age, gender and Index of Multiple Deprivation 2007 quintiles given four risk factor change scenarios: (a) assuming recent trends will continue; (b) assuming optimal but feasible levels already achieved elsewhere; (c) an intermediate point, halfway between current and optimal levels; and (d) assuming plateauing or worsening levels, the worst case scenario. These four scenarios were compared to the baseline scenario with both risk factors and CHD mortality rates remaining at 2007 levels. This would result in approximately 97,000 CHD deaths in 2020. Assuming recent trends will continue would avert approximately 22,640 deaths (95% uncertainty interval: 20,390-24,980). There would be some 39,720 (37,120-41,900) fewer deaths in 2020 with optimal risk factor levels and 22,330 fewer (19,850-24,300) in the intermediate scenario. In the worst case scenario, 16,170 additional deaths (13,880-18,420) would occur. If optimal risk factor levels were achieved, the gap in CHD rates between the most and least deprived areas would halve with falls in systolic blood pressure, physical inactivity and total cholesterol providing the largest contributions to mortality gains. Conclusions: CHD mortality reductions of up to 45%, accompanied by significant reductions in area deprivation mortality disparities, would be possible by implementing optimal preventive policies.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Modelling coronary heart disease mortality in Northern Ireland between 1987 and 2007: broader lessons for prevention
    Hughes, John
    Kee, Frank
    O'Flaherty, Martin
    Critchley, Julia
    Cupples, Margaret
    Capewell, Simon
    Bennett, Kathleen
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (02) : 310 - 321
  • [42] The effects of maximising the UK’s tobacco control score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study
    Kirk Allen
    Chris Kypridemos
    Lirije Hyseni
    Anna B. Gilmore
    Peter Diggle
    Margaret Whitehead
    Simon Capewell
    Martin O’Flaherty
    BMC Public Health, 16
  • [43] Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality
    Collet, Tinh-Hai
    Gussekloo, Jacobijn
    Bauer, Douglas C.
    den Elzen, Wendy P. J.
    Cappola, Anne R.
    Balmer, Philippe
    Iervasi, Giorgio
    Asvold, Bjorn O.
    Sgarbi, Jose A.
    Voelzke, Henry
    Gencer, Baris
    Maciel, Rui M. B.
    Molinaro, Sabrina
    Bremner, Alexandra
    Luben, Robert N.
    Maisonneuve, Patrick
    Cornuz, Jacques
    Newman, Anne B.
    Khaw, Kay-Tee
    Westendorp, Rudi G. J.
    Franklyn, Jayne A.
    Vittinghoff, Eric
    Walsh, John P.
    Rodondi, Nicolas
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (10) : 799 - 809
  • [44] Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
    Rodondi, Nicolas
    den Elzen, Wendy P. J.
    Bauer, Douglas C.
    Cappola, Anne R.
    Razvi, Salman
    Walsh, John P.
    Asvold, Bjorn O.
    Iervasi, Giorgio
    Imaizumi, Misa
    Collet, Tinh-Hai
    Bremner, Alexandra
    Maisonneuve, Patrick
    Sgarbi, Jose A.
    Khaw, Kay-Tee
    Vanderpump, Mark P. J.
    Newman, Anne B.
    Cornuz, Jacques
    Franklyn, Jayne A.
    Westendorp, Rudi G. J.
    Vittinghoff, Eric
    Gussekloo, Jacobijn
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12): : 1365 - 1374
  • [45] Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008
    Unal, Belgin
    Sozmen, Kaan
    Arik, Hale
    Gerceklioglu, Gul
    Altun, Deniz Utku
    Simsek, Hatice
    Doganay, Sinem
    Demiral, Yucel
    Aslan, Ozgur
    Bennett, Kathleen
    O'Flaherty, Martin
    Capewell, Simon
    Critchley, Julia
    BMC PUBLIC HEALTH, 2013, 13
  • [46] Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality
    Wijeysundera, Harindra C.
    Mitsakakis, Nicholas
    Witteman, William
    Paulden, Mike
    van der Velde, Gabrielle
    Tu, Jack V.
    Lee, Douglas S.
    Goodman, Shaun G.
    Petrella, Robert
    O'Flaherty, Martin
    Capewell, Simon
    Krahn, Murray
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (06) : 756 - 762
  • [47] Change in Mortality from Coronary Heart Disease and Stroke in Arkansas (1979 to 2007)
    Balamurugan, Appathurai
    Mehta, Paulette
    Bates, Joseph
    Mehta, Jawahar L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (02) : 156 - 160
  • [48] Standing Blood Pressure and Risk of Falls, Syncope, Coronary Heart Disease, and Mortality
    Kondo, Jordan K.
    Earle, William B.
    Turkson-Ocran, Ruth-Alma N.
    Ngo, Long H.
    Cluett, Jennifer L.
    Lipsitz, Lewis A.
    Daya, Natalie R.
    Selvin, Elizabeth
    Lutsey, Pamela L.
    Coresh, Josef
    Windham, Beverly Gwen
    Kendrick, Karla N.
    Juraschek, Stephen P.
    AMERICAN JOURNAL OF HYPERTENSION, 2023, 36 (11) : 593 - 601
  • [49] Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012
    Arroyo-Quiroz, Carmen
    O'Flaherty, Martin
    Guzman-Castillo, Maria
    Capewell, Simon
    Chuquiure-Valenzuela, Eduardo
    Jerjes-Sanchez, Carlos
    Barrientos-Gutierrez, Tonatiuh
    PLOS ONE, 2020, 15 (12):
  • [50] Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008
    Pereira, Marta
    Azevedo, Ana
    Lunet, Nuno
    Carreira, Helena
    O'Flaherty, Martin
    Capewell, Simon
    Bennett, Kathleen
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (06): : 634 - +